ANEW Medical - מכפיל P/S עתידי KLTO

Klotho Neurosciences Inc (KLTO) is currently implementing a long-term plan to develop innovative neurobiological treatments. The funding for preclinical trials of new drugs is based on attracted investments. The development of biologics based on the Klotho protein to combat dementia is supported by patents. The forward P/S ratio demonstrates market demand, with the parameter value equal to .
KLTO (anewmeds.com): פילוחים אנליטיים ודוחות לפי אינדיקטורים

Analyzing the forward price-to-sales ratio chart allows for an assessment of the market value of Klotho Neurosciences Inc (KLTO) through the lens of its scientific authority in neurodegeneration therapy. This indicator compares current market capitalization with expected sales, enabling investors to determine the business's margin of safety and identify hidden undervaluation or risks of declining demand for the company's innovative drugs.